Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy
NCT00234962
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infection
Interventions
DRUG:
Lopinavir/Ritonavir
Sponsor
Abbott